Ridazolol is a beta-adrenergic receptor (betaAR) antagonist. Ridazolol exhibits a high degree of selectivity for beta-1 adrenergic receptor (beta1AR) and possesses moderate intrinsic sympathomimetic activity (ISA). Ridazolol can competitively antagonize the relaxation effects induced by isoproterenol. Ridazolol is utilized in the research of cardiovascular diseases[1].
Molekulargewicht:
373.23
CAS Nummer:
[83395-21-5]
Formel:
C15H18Cl2N4O3
Target-Kategorie:
Adrenergic Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten